(Total Views: 52)
Posted On: 04/29/2019 12:25:40 PM
Post# of 25900

$CYTR News Article - CytRx Corporation Highlights Enrollment Completion in Phase 2/3 Clinical Trial of Sporadic Inclusion Body Myositis Conducted by Arimoclomol Licensee Orphazyme A/S https://marketwirenews.com/news-releases/cytr...75264.html


My Twitter: WhyteStocks